In Silico Drug Design and Analysis of Dual Amyloid-Beta and Tau Protein-Aggregation Inhibitors for Alzheimer’s Disease Treatment

Alzheimer’s disease (AD) is a progressive and irreversible neurodegenerative disorder that gradually leads to the state of dementia. The main features of AD include the deposition of amyloid-beta peptides (Aβ), forming senile plaques, and the development of neurofibrillary tangles due to the accumul...

Descripción completa

Detalles Bibliográficos
Autores principales: Job, Nisha, Thimmakondu, Venkatesan S., Thirumoorthy, Krishnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919237/
https://www.ncbi.nlm.nih.gov/pubmed/36771052
http://dx.doi.org/10.3390/molecules28031388

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9919237/
https://www.ncbi.nlm.nih.gov/pubmed/36771052
http://dx.doi.org/10.3390/molecules28031388

Ejemplares similares